In Depth 12 Sep 2024
New treatments being developed for schizophrenia
Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.
- Latest Posts
News and Trends 12 Sep 2024
Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges
Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D.
News and Trends 11 Sep 2024
Can Europe revive its biopharma innovation leadership?
Find out if the biotech runner-up, Europe, can step up to boost research and revive its innovation leadership.
News and Trends 10 Sep 2024
Long non-coding RNAs: what’s behind the growing “dark genome” buzz?
Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front.
Accelerating the path to clinical filing applications with rapid toxicology material delivery
Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials.
News and Trends 6 Sep 2024
Psychedelic therapies under scrutiny: What’s next after Lykos’ MDMA rejection?
Delve into the psychedelic-assisted therapy market and investors’ sentiment after the FDA’s decision about Lykos’ therapy.
ADVERTISEMENT
ADVERTISEMENT
Podcast 6 Sep 2024
The power of tumor infiltrating lymphocytes to fight melanoma
Listen to our conversation with Brian Gastman, EVP of medical affairs at Iovance Biotherapeutics, about TILs and the company’s pipeline.
In Depth 5 Sep 2024
The biggest private biotech investments in August 2024
The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024.
Best in Biotech 5 Sep 2024
Six biotech companies that could revolutionize obesity treatments
In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market.
News and Trends 4 Sep 2024
2024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
In Depth 3 Sep 2024
Adaptimmune: The long road toward finally bringing the first TCR-T cell therapy to the market
Find out about Adaptimmune’s long – and somewhat bumpy – road toward bringing the first TCR-T therapy to the market.
The crucial role of GS-CHO innovation in biopharmaceutical progress
Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins.
ADVERTISEMENT
